Modern transfusion medicine is sophisticated hemotherapy. Cellular and humoral blood components can be relevant in virtually every disease, either as a primary determinant in pathophysiology or as a victim of collateral damage, e.g. during treatment with cytostatic drugs, or as crucial substrates in replacement and hemostasis-navigated hemotherapy. With its interdisciplinary approach modern hemotherapy is a paragon of translational research bridging the bench-to-bedside gap in biomedicine. The state-of-the-art contributions collected here aim to stimulate lively discussions - not only among blood center professionals but also with blood and vascular biologists, hematologists, immunologists, anesthesiologists, intensive care specialists, surgeons, cardiologists, nephrologists, rheumatologists, and pulmonary and infectious disease specialists.
37 - 47: Intravascular and Extravascular Coagulation and Fibrinolysis in the Diseased Lung
Phillip Markart, Malgorzata Wygrecka, Clemens Ruppert, Martina Korfei, Bhola Dahal, Thorsten Jennes, Klaus T. Preissner, Werner Seeger, Andreas Günther, 2008. "Intravascular and Extravascular Coagulation and Fibrinolysis in the Diseased Lung", Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy: State of the Art 200841st Congress of the German Society for Transfusion Medicine and Immunohematology, Düsseldorf, September 2008, R.E. Scharf
Download citation file: